Breast cancer guidelines in Canada: A review of development and implementation

Breast Care

Volumn 3, Issue 2, 2008, Pages 108-113

  Folkes, Amy ^a   Urquhart, Robin ^a   Zitzelsberger, Louise ^b   Grunfeld, Eva ^a,b  

^a Cancer Outcomes Research Program   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Breast cancer; Clinical practice guidelines; Knowledge translation

Indexed keywords

BREAST CANCER; CANADA; CANCER SURGERY; CANCER THERAPY; CONSENSUS; EVIDENCE BASED MEDICINE; HEALTH CARE ORGANIZATION; HUMAN; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; REVIEW;

EID: 44949239543     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000121732     Document Type: Review

References (49)

1. President's Cancer Panel, Living Beyond Cancer: Finding a New Balance. Bethesda, MD, U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, 2004.
2. Committee on Cancer Survivorship: Improving Care and Quality of Life (National Cancer Policy Board): From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, D.C., Institute of Medicine and National Research Council of The National Academies Press, 2005.
3. National Institutes of Health Consensus Development Conference statement: Adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst Monogr 2001;30:5-15.
4. Committee on Clinical Practice Guidelines: Guidelines for Clinical Practice: From Development to Use. Washington, Institute of Medicine National Academy Press, 1992.
5. Woolf S, Grol R, Hutchinson B, Eccles M, Grimshaw J: Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 1999;318:527-530.
6. Canadian Institutes of Health Research: Knowledge Translation (KT) and Commercialization. www.cihr-irsc.gc.ca/e/29529.html.
7. Greene B: Breast Cancer: Unanswered Questions. Ottawa, Queen's printer, 1992.
8. Health Canada: Report on the National Forum on Breast Cancer. Ottawa, ON, 1994.
9. Goel V, Olivotto I, Hislop TG, Sawka C, Coldman A, Holowaty EJ: Patterns of initial management of node-negative breast cancer in two Canadian provinces. CMAJ 1997;156:25-35.
10. Iscoe NA, Goel V, Wu K, Fehringer G, Holowaty EJ, Naylor CD: Variation in breast cancer surgery in Ontario. CMAJ 1994;150:345-352.
11. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer: Introduction. CMAJ 1998;158:S1-S2.
12. Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer: Clinical practice guidelines for the care and treatment of breast cancer: a Canadian consensus document. CMAJ 1998;158:S1-83.
13. Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer: Clinical Practice Guidelines for the Care and Treatment of Breast Cancer (online). www.cmaj.ca/cgi/content/full/158/3/DC1.
14. Canadian Cancer Society: Our Cancer Information Services (online). www.cancer.ca/ccs/internet/standard/0,3182,3172_14495__langId-en,00.html.
15. Grunfeld E, Sukhbinder D, Levine M: Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ 2005;172:1319-1320.
16. Cancer Care Ontario: Breast Cancer Evidence-Based Series and Practice Guidelines (online). www.cancercare.on.ca/english/toolbox/qualityguidelines/ diseasesite/breast-ebs.
17. British Colombia Cancer Agency: Cancer Management Guidelines: Breast (online). www.bccancer.bc.ca/HPI/CancerManagementGuidelines/Breast/ 1TumourSiteTypeDemographics.htm.
18. Grunfeld E: Canadian breast cancer guidelines are as effective as possible under the circumstances. CMAJ 2007;176:785-786.
19. Olivotto IA, Coldman AJ, Hislop TG, Trevisan CH, Kula J, Goel V, Sawka C: Compliance with practice guidelines for node-negative breast cancer. J Clin Oncol 1997;15:216-222.
20. Chua B, Olivotto IA, Weir L, Kwan W, Truong P, Ragaz J: Increased use of adjuvant regional radiotherapy for node-positive breast cancer in British Colombia. Breast J 2004;10:38-44.
21. Hebert-Croteau N, Brisson J, Latreille J, Gariepy G, Blanchette C, Deschenes L: Time trends in systemic adjuvant treatment for node-negative breast cancer. J Clin Oncol 1999;17:1458-1464.
22. Iscoe NA, Naylor D, Williams I, DeBoer G, Morgan MW, Fehringer G, Holowaty E: Temporal trends in breast cancer surgery in Ontario: can one randomized trial make a difference? CMAJ 1994;150:1109-1115.
23. Early Breast Cancer Trialists' Collaborative Group: Effect of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomized trials among 28,896 women. N Engl J Med 1988;319:1558.
24. The Ludwig Breast Cancer Study Group: Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med 1989;320:491-496.
25. Fisher B, Redmond C, Dimitrov N, Bowman D, Legault-Poisson S, Wickerham DL, Wolmark N, Fisher E, Margolese R, Sutherland C, Glass A, Foster R, Caplan R: A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med 1989;320:473-478.
26. Fisher B, Costantino J, Redmond C, Poisson R, Bowman D, Couture J, Dimitrov NV, Wolmark N, Wickerham DL, Fisher ER, Margolese R, Robidoux A, Shibata H, Terz J, Paterson AHG, Feldman MI, Farrar W, Evans J, Lickley HL, Ketner M: A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 1989;320:479-484.
27. Mansour EG, Gray R, Shatila AH, Osborne CK, Tormey DC, Gilchrist KW, Cooper MR, Falkson G: Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer: an intergroup study. N Engl J Med 1989;320:485-490.
28. Latosinsky S, Fradette K, Lix L, Hildebrand K, Turner D: Canadian breast cancer guidelines: have they made a difference? CMAJ 2007;176:771-776.
29. Sheldon TA, Cullum N, Dawson D, Lankshear A, Lowson K, Watt I, West P, Wright D, Wright J: What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews. BMJ 2004;329.
30. Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer: The palpable breast lump: information and recommendations to assist decision-making when a breast lump is detected. CMAJ 1998;158:S3-8.
31. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, Whitty P, Eccles MP, Matowe L, Shirran L, Wensing W, Dijkstra R, Donaldson C: Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004;8:1-72.
32. Gross PA, Greenfield S, Cretin S, Ferguson J, Grimshaw J, Grol R, Klazinga N, Lorenz W, Meyer GS, Riccobono C, Schoenbaum SC, Schyve P, Shaw C: Optimal methods for guideline implementation: conclusions from Leeds Castle Meeting. Med Care 2001;39:II85-II92.
33. Davis DA, Taylor-Vaisey A: Translating guidelines into practice: A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ 1997;157:408-416.
34. Lomas J: Teaching old (and not so old) docs new tricks: effective ways to implement research findings, Working Paper 934. McMaster University Centre for Health Economics and Policy Analysis, Toronto, 1993.
35. Grol R: Implementing guidelines in general practice care. Qual Health Care 1992;1:184-191.
36. Oxman AD, Thomson MA, Davis DA, Haynes B: No magic bullets: a systematic review of 102 trials on interventions to improve professional practice. CMAJ 1995;153:1423-1431.
37. Grunfeld E, Zitzelsberger L, Hayter C, Berman N, Cameron R, Evans WK, Stern H: The role of knowledge translation for cancer control in Canada. Chron Dis Can 2004;25:1-6.
38. Davis D, Goldman J, Palda V: Handbook on Clinical Practice Guidelines. Canadian Medical Association, 2007.
39. Canadian Partnership Against Cancer: Canadian Partnership Against Cancer (online). www.partnershipagainstcancer.ca.
40. Browman G, Zitzelsberger L, Boscaino A: Harnessing evidence to optimize cancer control: a pan-Canadian approach. Oncol Exch 2005;4:22-25.
41. ADAPTE: Guideline Adaptation (online). www.adapte.org/index.php.
42. Cancer Care Ontario: Cancer System Quality Index 2007: Completeness of Pathology Reporting (online). www.cancercare.on.ca/qualityindex2007/ measurement/pathologyReports/index.html.
43. Abidi S, Abidi SSR, Hussain S, Shepherd M: Ontology-Based Modelling of Clinical Practice Guidelines: A Clinical Decision Support System for Breast Cancer Follow-Up Interventions at Primary Care Settings. 2nd World Congress on Medical Informatics (MEDINFO2007). Brisbane, IOS Press, 2007.
44. Lobach DF, Hammond WE: Computerized decision support based on a clinical practice guideline improves compliance with care standards. Am J Med 1997;102:89-98.
45. Zitzelsberger L, Grunfeld E, Graham I: Family physicians' perspectives on practice guidelines related to cancer control. BMC Fam Pract 2004;5:25.
46. The College of Family Physicians of Canada. National Physician Survey 2007 (online). www.cfpc.ca/English/cfpc/research/janus%20project/default.asp? s=1.
47. Hunt DL, Haynes RB, Hanna SE, Smith K: Effects of computer-based clinical decision support systems on physician performance and patient outcomes. A systematic review. JAMA 1998;280:1339-1346.
48. DiCenso A, Virani T, Bajnok I, Borycki E, Davies B, Graham I, Harrison M, Logan J, McCleary L, Power M, Scott J: A toolkit to facilitate the implementation of clinical practice guidelines in healthcare settings. Hosp Q 2002;5:55-60.
49. Grunfeld E (principal investigator): A Randomized Trial of Patient-Centred Strategy to Facilitate Transition of Breast Cancer Survivors' Routine Follow-up from Specialist to Primary Care. Canadian Breast Cancer Research Alliance/National Cancer Institute of Canada, 2006-2010.